文献速递冠心病外科瓣膜外科

低射血分数患者常规心脏手术结局

Outcomes of Conventional Cardiac Surgery in Patients With Severely Reduced Ejection Fraction in the Modern Era.
PubMed 文献 · Ann Thorac Surg · 2019-09-23

该研究评估左心室射血分数(LVEF)≤25%患者接受常规心脏手术的结局。2010至2018年共588例低LVEF患者接受STS索引手术,主要结局为生存率,次要结局为并发症和再入院率。低LVEF患者手术类型不影响生存,传统危险因素如高龄和合并症影响生存;术前使用正性肌力药物者生存率降低,但多数患者5年仍存活。倾向匹配后低LVEF与LVEF>25%患者生存率相似。

要点

  • 低LVEF患者可接受常规心脏手术,结局可接受。
  • 手术类型不影响低LVEF患者生存,高龄和合并症是关键风险因素。
  • 术前使用正性肌力药物与生存率降低相关,但多数5年仍存活。

核心结论

  • 尽管风险较高,术前LVEF降低患者仍可接受常规心脏手术并获得可接受的结局,多数患者5年时存活且无心衰再入院。

研究设计与样本

  • 回顾性队列研究,纳入2010至2018年接受STS索引心脏手术的术前LVEF≤25%患者588例,采用多变量Cox回归进行风险调整,并进行倾向匹配分析。

主要发现

  • 低LVEF组中单纯冠状动脉旁路移植术397例(67.5%),单纯瓣膜手术51例(8.67%),冠状动脉旁路移植联合瓣膜手术140例(23.8%)。
  • 低LVEF患者生存不受手术类型影响,而受高龄和合并症等传统危险因素影响。
  • 5年随访时无心衰再入院生存率为57.2%。
  • 倾向匹配后,LVEF≤25%与LVEF>25%患者在30天、1年和5年随访时生存率和死亡风险相似。

临床怎么用

  • 对于LVEF≤25%的高危患者,常规心脏手术仍可考虑,但需评估高龄和合并症等风险因素。
  • 术前使用正性肌力药物提示预后较差,应优化术前状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study evaluates the outcomes of conventional cardiac surgery in patients with a left ventricular ejection fraction (LVEF) of 25% or less. METHODS: Patients with preoperative low LVEF (25% or less) undergoing The Society of Thoracic Surgeons (STS) indexed cardiac operations from 2010 to 2018 were included. The primary outcome was survival. Secondary outcomes included major postoperative complications and readmission rates. Multivariable Cox regression was utilized for risk adjustment. Subanalyses evaluated the effect of preoperative inotropes as well as the impact of low LVEF on survival and readmission compared with propensity matched patients with LVEF greater than 25%. RESULTS: In all, 9467 patients underwent STS-indexed cardiac operations during the study period, including 588 with LVEF of 25% or less. The low LVEF group included 397 (67.5%) isolated coronary artery bypass graft, 51 (8.67%) isolated valve, and 140 (23.8%) concomitant coronary artery bypass graft and valve operations. Survival of low LVEF patients was not affected by operative procedure but instead by traditional risk factors such as advanced age and medical comorbidities. Freedom from hospital readmission for heart failure was 57.2% at 5-year follow-up. Patients receiving preoperative inotropes had reduced survival, although the majority were still alive at 5 years (53.1% vs 64.9%, P = .002). In addition, propensity matched patients with LVEF 25% or less and LVEF greater than 25% had similar survival and hazards for mortality at 30-day, 1-year, and 5-year follow-up. CONCLUSIONS: Despite a high-risk profile, patients with reduced preoperative LVEF can undergo conventional cardiac surgery with acceptable outcomes. The majority of patients, including those receiving preoperative inotropes, were alive and free from heart failure readmissions at 5 years.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Seese L, Sultan I, Gleason T, et al. Outcomes of Conventional Cardiac Surgery in Patients With Severely Reduced Ejection Fraction in the Modern Era. Ann Thorac Surg. 2019. PMID: 31557479. doi:10.1016/j.athoracsur.2019.08.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。